Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    May 2017
  1. MAGUBANE M, Michel FS, Erlwanger KH, Norton GR, et al
    Prevention of betaeta-Adrenergic-Induced Adverse Cardiac Remodelling by Gonadectomy in Male but not Female Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2017 May 30. doi: 10.1097/FJC.0000000000000506.
    PubMed     Text format     Abstract available


  2. JAIN M, Bhosale V, Tripathi D, Singh H, et al
    Antihypertensive drugs aliskiren, nebivolol, and olmesartan reduce hypertension by reducing endothelial microparticle and regulating angiogenesis.
    J Cardiovasc Pharmacol. 2017 May 9. doi: 10.1097/FJC.0000000000000503.
    PubMed     Text format     Abstract available


    March 2017
  3. IZZO JL JR, Zappe DH, Jia Y, Hafeez K, et al
    Efficacy and safety of crystalline valsartan/sacubitril (LCZ696) compared to placebo and combinations of free valsartan and sacubitril in patients with systolic hypertension: the RATIO study.
    J Cardiovasc Pharmacol. 2017 Mar 23. doi: 10.1097/FJC.0000000000000485.
    PubMed     Text format     Abstract available


  4. PETTINGER WA
    Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.
    J Cardiovasc Pharmacol. 2017;69:129-139.
    PubMed     Text format     Abstract available


  5. JACKSON EK
    Editorial for "Hypertension's 3 Dilemmas & 3 Solutions: Pharmacology of the Kidney in Hypertension".
    J Cardiovasc Pharmacol. 2017;69:127-128.
    PubMed     Text format    


    October 2016
  6. CAMPOS C, Luz de Castro A, Vicente Tavares AM, Fernandes RO, et al
    Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016

  7. Morphological Identification of TRPC7 in Cardiomyocytes from Normal and Renovascular Hypertensive Rats: Retraction.
    J Cardiovasc Pharmacol. 2016;68:96.
    PubMed     Text format    


    April 2016
  8. LIU X, Duan P, Hu X, Li R, et al
    Altered KATP channel subunits expression and vascular reactivity in spontaneously hypertensive rats with age.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  9. DEMIR M, Gurol AO, Ozyigit RT, Uresin AY, et al
    Effects of Blood Pressure Lowering with Different Antihypertensive Agents on Cognitive Function and Plasma Brain-Derived Neurotrophic Factor Levels: A Comparative Study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  10. FARES WH
    Pushing the Envelope on the Indications and Doses of Pulmonary Arterial Hypertension Medications: What's Reasonable?
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format    


    January 2016
  11. PARIKH KS, Rajagopal S, Fortin T, Tapson VF, et al
    Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  12. LI Y, Geng X, Wang H, Cheng G, et al
    CTRP9 ameliorates pulmonary-arterial hypertension through attenuating inflammation and improving endothelial cell survival and function.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  13. VIRDIS A, Taddei S
    Endothelial Dysfunction In Resistance Arteries Of Hypertensive Humans: Old And New Conspirators.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  14. AKAGI S, Nakamura K, Matsubara H, Kondo M, et al
    Intratracheal administration of prostacyclin analog-incorporated nanoparticles ameliorates the development of monocrotaline and sugen/hypoxia-induced pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  15. SHANG P, He ZY, Chen JF, Huang SY, et al
    Absence of the Adenosine A2A Receptor Confers Pulmonary Arterial Hypertension Through RhoA/ROCK Signaling Pathway in Mice.
    J Cardiovasc Pharmacol. 2015;66:569-75.
    PubMed     Text format     Abstract available


    November 2015
  16. MARTINEZ-AGUILAR L, Lezama-Martinez D, Orozco-Cortes NV, Gonzalez-Espinosa C, et al
    Antihypertensive properties of a the novel morphologic derivative (4-tert-buthyl-2,6-bis (thiomorpholine-4-ilmethyl)phenol).
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


  17. LINZ B, Hohl M, Reil JC, Bohm M, et al
    Inhibition of NHE3-mediated sodium absorption in the gut reduced cardiac end-organ damage without deteriorating renal function in obese spontaneously hypertensive rats.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  18. MONTO F, Oliver E, Vicente D, Buendia F, et al
    beta2- AND beta1-ADRENOCEPTOR EXPRESSION EXHIBIT A COMMON REGULATORY PATTERN WITH GRK2 AND GRK5 IN HUMAN AND ANIMAL MODELS OF CARDIOVASCULAR DISEASES.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: